Back to Transactions
Healthcare
2025

Helix Acquisition Corp. II has agreed to merge with BridgeBio Oncology Therapeutics

Client: Helix Acquisition Corp. II

Client Location: United States

Target: BridgeBio Oncology Therapeutics

Target Location: United States

Target Description: BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. Initially formed as a subsidiary of BridgeBio Pharma, Inc. (Nasdaq: BBIO), BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, visit bridgebiooncology.com.

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team

William Epstein
Individual board members have different levels of sophistication and I find it my obligation to distill the financial information in sometimes complicated, bet-the-firm transactions into easy to understand presentations.

William Epstein

Managing Director

Los Angeles

Michael Schmit
I provide best-in-class advisory services with a strong focus on honesty and trust, which is a material component of the overall deliverable for my clients.

Michael Schmit

Vice President

Atlanta

View More Transactions in Valuations & Opinions

Lincoln International advised Tikehau Capital on the launch of its continuation fund to support Egis’ next phase of growth

Business Services

Lincoln International has advised Seven2 on a continuation vehicle transaction involving Marlink and Crystal

Lincoln International advised Ambienta on completing a single asset continuation vehicle transaction involving Wateralia

Industrials

Lincoln International is pleased to announce IBEX Limited has repurchased shares from The Resource Group International, Limited

Business Services

Lincoln International advised Hivest Capital Partners on a single asset continuation vehicle involving Agora Makers.

Industrials

Lincoln International advised Closure Systems International, a portfolio company of Cerberus Capital Management, has completed a leveraged dividend recapitalization

Consumer

Lincoln International advised Levine Leichtman Capital Partners on completing a multi-asset continuation vehicle transaction involving Blue Ridge ESOP Associates, Milton Industries, and Resolution Economics

Business Services

Lincoln International advised Phoenix Equity Partners in completing a multi-asset continuation vehicle transaction involving Nineteen Group and Envisage Dental

Healthcare
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.